Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 689 results for "pfizer"

AstraZeneca smashes forecasts in Q2 after seeing off Pfizer

AstraZeneca smashes forecasts in Q2 after seeing off Pfizer

ASTRAZENECA SMASHES FORECASTS IN Q2 AFTER SEEING OFF PFIZER@ LONDON, July 31 (Reuters) - AstraZeneca smashed forecasts for second-quarter sales and earnings on Thursday, demonstrating resilience after seeing off a $118 billion takeover approach ... CNBC, 1 hour ago

2,728 images for pfizer

WTAQ News Talk, 1 day ago, 1 day ago
American Banking News, 1 day ago
WKZO-AM, 2 days ago, 1 day ago
BusinessWeek, 1 day ago
WBSM-AM, 2 days ago
Hartford Courant, 1 day ago
Chicago Tribune, 1 day ago, 19 hours ago

Pfizer adds Baxter vaccines

pharmaceuticals Dr Drug maker Pfizer agreed to buy Baxter International's vaccines unit and a part of a production facility for $635m (€475m). The deal will give Pfizer access to Baxter's meningitis vaccine, NeisVac-C, and its encephalitis ...
 Irish Independent4 hours ago Pfizer to Acquire Vaccines from Baxter  PharmTech.com8 hours ago Pfizer - Guides Lower Again, Uncertainty About The Future Strategy Remains  Seeking Alpha11 hours ago Pfizer will pay $635M to buy 2 Baxter Int'l vaccines with $300M in combined overseas sales  FOXBusiness.com13 hours ago

ASTRA AND PFIZER : it's a conscious uncoupling

DRUGMAKERS Astrazeneca and Pfizer yesterday put to bed their "will they, won't they" bromance by signing new deals with other companies. FTSE 100-listed Astrazeneca , which fought off a £69bn takeover approach from larger US rival Pfizer in late ...
 4 Traders1 hour ago Pfizer's profit sinks  IOL1 day ago Pfizer Inc. CEO Aggressively Seeking Deals, Leaves Investors Guessing On AstraZeneca PLC Intentions  BioSpace17 hours ago Pfizer Beats Forecasts Despite Slumping Sales  RTTNews.com1 day ago

Pfizer profit falls 79 percent in Q2

(MENAFN) Earnings of Pfizer dropped 79 percent in the second quarter compared to last year, when the world"s second-largest drugmaker booked a business spinoff gain of more than USD10 billion, according to Arab News. The company's earnings were ...
 MENAFN22 hours ago Pfizer net earnings dips by 79% in Q2 to $2,912 million  PharmaBiz23 hours ago Pfizer posts drop in Q2 profit, sales; trims annual revenue guidance on Celebrex generics  FirstWord Pharma1 day ago

Pfizer (PFE) Showing Bearish Technicals With Resistance At $30.77

After TuesdayaEUR(TM)s trading in Pfizer Inc. ("PFE)'s patented algorithms uncovered a trade that offers a 3.42% return or 5.36% on an annualized basis (for comparison ...
 Individual.com18 hours ago Pfizer's (PFE) CEO Ian Read on Q2 2014 Results - Earnings Call Transcript  Seeking Alpha1 day ago Pfizer chief says shareholders supportive of decision to walk away from AstraZeneca  Seeking Alpha1 day ago Is Pfizer Inc. (PFE) Poised to Beat Earnings Estimates?  Yahoo! Finance2 days ago

Shares of Pfizer Under Pressure, Down 2.0%

Pfizer (NYSE:PFE) is one of today's biggest movers, down 2.0% to $29.12. The Dow Jones Industrial Average is now trading 0.4% lower to 16,842 and the S&P is trading 0.2% lower
 Individual.com14 hours ago

Baxter's Vaccine Business Lands at Pfizer; No Fair Value Changes

A trusted brand and an unrivaled product and services portfolio hold IBM in good stead. Thesis 01/30/2012 IBM's technological leadership and sticky products and services will enable the company to deliver steady ...
 Morningstar.com16 hours ago

Pfizer still set on tax inversion

04:49 ET | About: Pfizer Inc. (PFE) Pfizer (NYSE:PFE) is still looking to complete it highly desired tax inversion, despite AstraZeneca's rejection of its £69.4B takeover bid in May. CEO Ian Read is lobbying in Washington for an overhaul of tax ...
 Seeking Alpha22 hours ago
Pharma Letter

New indications approved in EU for Bristol-Myers/Pfizer Eliquis

The European Commission has approved US pharma majors Bristol-Myers Squibb (NYSE: BMY) and Pfizer's (NYSE: PFE) Eliquis (apixaban) for the additional indications of the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and the ...
 Pharma Letter14 hours ago European Commission approves BMS- Pfizer's Eliquis to treat DVT, PE  Pharmaceutical Business Review15 hours ago Bristol-Myers, Pfizer Announces EC Approval Of Eliquis For DVT & PE Treatment  RTTNews.com1 day ago EU expands use of PfizerB-MS bloodthinner Eliquis  Big News Network20 hours ago

PFIZER : Pharmaceuticals organizes cardiovascular disease Summit

 4 Traders13 hours ago Pfizer Pharmaceuticals organizes cardiovascular disease Summit  Ghana News Agency5 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - pfizer
Get updated on latest news & your favorite topics right in your inbox!
More     Less